Physician profile
Susan Logan
NPI 1982716221
$5,160.50
in general payments reported to CMS, 2019-2025
38 companies · $697 in 2025
The $697 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $560 · 2021: $685 · 2022: $935 · 2023: $759 · 2024: $909 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,162 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,162.26 |
| Education | $202.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $676.60 | 2021-2025 | |
| Hologic Sales and Service, LLC | $653.16 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Abbvie INC. | $644.88 | 2019-2025 | |
| Astellas Pharma US INC | $603.08 | 2020-2025 | Veozah, Myrbetriq |
| Organon LLC | $359.34 | 2021-2025 | Nexplanon |
| Pfizer INC. | $236.40 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $201.78 | 2019-2021 | |
| Therapeuticsmd, INC. | $199.19 | 2019-2022 | |
| Myovant Sciences INC. | $127.77 | 2021-2022 | |
| Biogen, INC. | $115.62 | 2025 | Zurzuvae |
| Amgen INC. | $98.20 | 2019-2020 | |
| Millicent US INC | $97.55 | 2024-2025 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $96.21 | 2021-2022 | |
| Meditrina | $96.21 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $93.41 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $85.22 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $78.38 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $70.92 | 2022 | |
| Merck Sharp & Dohme LLC | $62.85 | 2019-2021 | |
| Avanos Medical | $52.22 | 2022-2025 | On-Q Pump and Accessories |
| Mimedx Group, INC. | $43.58 | 2024-2025 | |
| Lupin INC. | $43.52 | 2019-2020 | |
| Aspira Women'S Health INC | $39.62 | 2022-2024 | Ova1 |
| Allergan, INC. | $37.39 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.08 | 2019-2020 | |
| Baxter Healthcare | $35.73 | 2024 | Adept |
| Molnlycke Health Care US, LLC | $35.61 | 2022 | |
| Sage Therapeutics, LLC | $30.41 | 2021 | |
| Becton, Dickinson and Company | $30.16 | 2022 | |
| Roche Diagnostics Corporation | $30.15 | 2019 | |
| Sumitomo Pharma America, INC. | $21.36 | 2023 | Myfembree |
| Laborie Medical Technologies Corp. | $21.06 | 2025 | Eclipse |
| Agile Therapeutics, INC. | $20.76 | 2022 | |
| Axonics, INC. | $20.31 | 2021 | |
| Merz North America, INC. | $18.49 | 2020 | |
| Abbott Laboratories | $17.10 | 2021 | |
| Ethicon US, LLC | $14.60 | 2019 | |
| Minerva Surgical, INC | $14.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.